Trials / Conditions / Radiation Pneumonitis

Radiation Pneumonitis

23 registered clinical trials studyying Radiation Pneumonitis — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Si NCT07339644	The Second Affiliated Hospital of Chongqing Medical University	N/A
Active Not Recruiting	Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy NCT07312682	The Second Affiliated Hospital of Chongqing Medical University	—
Unknown	The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia NCT06079931	Fifth Affiliated Hospital, Sun Yat-Sen University	Phase 2
Recruiting	Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiother NCT06557343	NHS Lothian	—
Recruiting	Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC NCT06570317	Second Hospital of Shanxi Medical University	—
Recruiting	Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort NCT06069115	Meshalkin Research Institute of Pathology of Circulation	—
Completed	The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis NCT06861179	Zhejiang Cancer Hospital	Phase 1
Recruiting	Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis NCT05189496	Guangdong Provincial People's Hospital	N/A
Recruiting	Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer NCT04676828	University of Aarhus	N/A
Recruiting	FAPI PET for Lung Fibrosis NCT05365802	University of California, Los Angeles	EARLY_Phase 1
Recruiting	A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis NCT05448703	Huazhong University of Science and Technology	—
Unknown	Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cel NCT04632342	Hanlim Pharm. Co., Ltd.	Phase 2
Recruiting	Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients NCT03803787	Instituto Nacional de Cancerologia de Mexico	Phase 2
Completed	Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis NCT03796364	Xinqiao Hospital of Chongqing	Phase 2
Completed	Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis NCT02735746	Cedars-Sinai Medical Center	—
Unknown	Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients NCT02809456	Taipei Medical University WanFang Hospital	Phase 2
Unknown	Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury NCT02296281	Beijing Continent Pharmaceutical Co, Ltd.	Phase 2
Completed	Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning. NCT04863027	Centre hospitalier de l'Université de Montréal (CHUM)	—
Completed	Mitigation of Radiation Pneumonitis and Fibrosis NCT01754909	VA Office of Research and Development	Phase 2
Completed	Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation NCT01745484	University of Aarhus	N/A
Completed	Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology NCT03462524	St. James's Hospital, Ireland	—
Unknown	Study on the Biological Prediction Models of Radiation Pneumonitis NCT02490319	Huazhong University of Science and Technology	—
Unknown	Risk Factors of Radiation Pneumonitis NCT00155909	National Taiwan University Hospital	—